Good day, and thank you for standing by. Welcome to the Rocket Lab Corporation Q1 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like ...

Rocket Lab achieved a record $200.3 million in revenue, a 63.5% YoY increase. The company’s gross margins exceeded expectations, with non-GAAP margins at 43%. The total backlog surged to $2.2 billion, ...

Earnings call Rocket Lab posted record Q1 2026 revenue of $200.3 million, up 63.5% YoY and above guidance, with GAAP gross margin at 38.2%. Backlog surged to $2.2 billion (+108% YoY), and management ...

Murielle Baker: Hello, and welcome to today's conference call to discuss Rocket Lab USA, Inc.'s First Quarter 2026 Financial Results, Business Highlights, and Other Updates. Before we begin the call, ...

Zai Lab’s performance in Q1 2026 was marked by a mixed financial outcome. The company managed to deliver a better-than-expected EPS, indicating effective cost management. However, the 6% ...

Zai Lab beat EPS expectations with a smaller-than-expected loss. Revenue fell short of forecasts, declining 6% year-over-year. Stock price dropped 2.33% in premarket trading. The company maintains a ...

Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's First Quarter 2026 Financial Results Conference Call. [Operator Instructions] As a reminder, today's call is being ...

Newark, Delaware--(Newsfile Corp. - April 28, 2026) - Podcast Transcript AI, a free online platform that turns podcast episodes and audio files into searchable text transcripts, today announced a ...

New litigation alleges the wellness guru’s ex-girlfriend was targeted in a mud-slinging scheme following a 2024 New York Magazine investigation about him. By Gary Baum Senior Writer In March 2024, New ...

Hello, and welcome to Rocket Lab's Fourth Quarter and Full Year 2025 Earnings Conference Call [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to ...

All right. Okay. Great. Thank you. I'm Yigal Nochomovitz, biotech analyst here at Citi in New York. This is the second day of our Virtual Oncology Summit. It's my pleasure to have with me from Zai Lab ...